Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG

News Daily News

AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG

November 17, 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

News Conference News ESC 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

August 27, 2022

EchoNet AI Algorithm Beats Sonographers for Estimating LV Function

News Conference News ESC 2022

EchoNet AI Algorithm Beats Sonographers for Estimating LV Function

August 27, 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

August 26, 2022

Early LV Recovery After TAVI Points to Better 5-Year Survival

News Daily News

Early LV Recovery After TAVI Points to Better 5-Year Survival

Yael L. Maxwell

August 01, 2022

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

News Daily News

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Michael O'Riordan

July 20, 2022

Triggers for Palliative Care in Advanced HF: Many Opportunities

News Daily News

Triggers for Palliative Care in Advanced HF: Many Opportunities

July 18, 2022

Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off

News Daily News

Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off

Yael L. Maxwell

June 16, 2022

June 2022 News Roundup

News Opinion CV Team Dispatch

June 2022 News Roundup

June 01, 2022

New HF Guidelines Stress Four Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

April 01, 2022

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.